Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone preemptive epidural analgesia and postpartum depression
ChiCTR2500101915Phase 4Not yet recruiting
- Sponsor
- Jiangxi Provincial People's Hospital
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydromorphone in postpartum depression (PPD) and labor pain (3 arms), sponsored by Jiangxi Provincial People's Hospital. Primary endpoint: Postpartum depression (EPDS score at 24 hours and 42 days postpartum). Planned start Jan 2025; status: not yet recruiting.
02
Drugs
hydromorphone
03
Conditions
postpartum depression (PPD)labor pain
Beyond the preview
Go deeper on ChiCTR2500101915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101915.